综上所述，针对晚期肿瘤患者实施中医药姑息治疗的临床优势显著，建议在临床中推广使用。

[1]廖峰,华海清,秦叔逵,等.阿帕替尼多线治疗晚期肺神经内分泌癌获部分缓解1例[J].临床肿瘤学杂志,2017,22(5):474-475.

[2]杨格娟,杜业勤.恶性肿瘤姑息治疗临床经验回顾[J].内蒙古中医药,2017,36(7):13-14.

[3]亓润智,杨玉莹,吴显文.吴显文以健运中焦法治疗恶性肿瘤经验[J].北京中医药,2018,37(3):238-239.

[4]Nieder C, Dalhaug A, Haukland E, et al. Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy[J]. Journal of Clinical Medicine Research,2017,9(3):183-187.

[5]殷东风,周立江,高宏,等. 中医药初始介入联合强阿片类药双轨滚动互助-缓慢升阶癌痛治疗方案[J].实用中医内科杂志,2018,32(3):7-11.

[6]郭志峰.姑息治疗晚期恶性肿瘤患者的临床效果分析[J].临床医药文献电子杂志,2017,4(59):43-44.

[7]Wu W, Yan S, Liao X, et al. Curative versus palliative treatments for colorectal cancer with peritoneal carcinomatosis: a systematic review and metaanalysis:[J].Oncotarget,2017,8(68):-.

[8]谭婉燕,熊枝繁.中药抗肿瘤临床应用的相关思考[J].山西医科大学学报,2017,48(9):966-967.

文章来源：《肿瘤药学》 网址: http://www.zlyxzz.cn/qikandaodu/2021/0709/1451.html